1 Patent
- US118847182024Potent Zika Virus-specific and Cross-neutralizing Monoclonal Antibodies to Zika and Dengue Viruses Following ZIKV Infection or Vaccination
The Government Of The United States As Represented By The Secretary Of The Army
0 cites